Photoacoustic Imaging (PAI) of the Prostate: A Clinical Feasibility Study
|ClinicalTrials.gov Identifier: NCT01551576|
Recruitment Status : Suspended (logistics)
First Posted : March 12, 2012
Last Update Posted : August 19, 2019
|Condition or disease|
The primary objective of this pilot study is to assess PAI-performance in a clinical setting to understand limitations of our current PAI instrumentation and to help improve the next-generation design.
To do preliminary evaluations of oxygen saturation in lesions based on PAI-measurements in order to distinguish malignant from benign prostatic tissue as a basis for future studies.
|Study Type :||Observational|
|Estimated Enrollment :||20 participants|
|Official Title:||Photoacoustic Imaging (PAI) of the Prostate: A Clinical Feasibility Study|
|Study Start Date :||February 2014|
|Estimated Primary Completion Date :||December 2020|
|Estimated Study Completion Date :||June 2021|
- lesion signal intensity on Photoacoustic Imaging (PAI) in relation to different lesion characteristics and the surrounding tissues [ Time Frame: 36 months ]The types of measures can be divided into three groups: 1) Operator determined measures during or just after the examination; 2) Post processing measures determined during post processing of the captured data and images; 3) Measures related to standard imaging and histopathological examination.
Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT01551576
|United States, California|
|Stanford University Cancer Institute|
|Stanford, California, United States, 94305|
|Principal Investigator:||Sanjiv S Gambhir, MD, PhD||Stanford University|
|Principal Investigator:||Martin Karl Schneider, PhD||Stanford University|